risks of glp 1 injections Overdose increase as demand for injectable weight-loss drugs on the rise, research finds Peptide/GLP-1 Complications: 11 Hidden Risks
Description
This includes medicines like Ozempic (semaglutide)
At Family Health Care, treatment decisions are always individualized
The core dispute: telehealth compounded semaglutide vs FDA-approved drugs Novo Nordisk manufactures several FDA-approved GLP-1 medications, including Ozempic, Wegovy, and Rybelsus, which use the active ingredient semaglutide to regulate blood sugar and appetite
Patient Perspective: Many patients with type 2 diabetes are now aware of GLP-1 drugs and may request them, especially due to the appeal of weight loss
